#BIO22: Fireside chat with Zachary Brennan and Ian Thompson

Zachary Brennan:

Hello, and welcome to today’s Fireside Chat. I’m Zachary Brennan, senior editor at Endpoints News and with me today is Ian Thompson, senior vice president of Amgen.

Today we’ll be discussing the evolution of the US biosimilar space, which has seen not only…